UBI — Universal Biosensors Income Statement
0.000.00%
Last trade - 00:00- AU$17.29m
- AU$9.49m
- AU$6.28m
- 21
- 41
- 27
- 20
Annual income statement for Universal Biosensors, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.2 | 5.78 | 4.52 | 6.63 | 6.28 |
| Cost of Revenue | |||||
| Gross Profit | 0.623 | 2.11 | 2.14 | 4.28 | 4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 15.8 | 20.7 | 39.4 | 23.3 | 23.3 |
| Operating Profit | -12.6 | -14.9 | -34.9 | -16.7 | -17 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.64 | -10.5 | -29.9 | -6.74 | -14.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.64 | -10.5 | -26.9 | -6.74 | -14.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.64 | -10.5 | -26.9 | -6.74 | -14.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.64 | -10.5 | -26.9 | -6.74 | -14.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.041 | -0.057 | -0.094 | -0.03 | -0.053 |